Legislative Research: US HB6 | 2015-2016 | 114th Congress
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 118th Congress (Introduced - Dead) | Reserved for the Speaker. [HB6 2023 Detail][HB6 2023 Text][HB6 2023 Comments] | 2023-01-03 Introduced in House |
| 2021-2022 117th Congress (Engrossed - Dead) | To authorize the cancellation of removal and adjustment of status of certain aliens, and for other purposes. [HB6 2021 Detail][HB6 2021 Text][HB6 2021 Comments] | 2021-06-15 Committee on the Judiciary. Hearings held. |
| 2019-2020 116th Congress (Engrossed - Dead) | Cancels and prohibits removal proceedings against certain aliens and provides such aliens with a path toward permanent resident status. The Department of Homeland Security (DHS) or the Department of Justice (DOJ) shall cancel removal proceedings agai... [HB6 2019 Detail][HB6 2019 Text][HB6 2019 Comments] | 2019-06-10 Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 112. |
| 2017-2018 115th Congress (Passed) | SUPPORT for Patients and Communities Act Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act TITLE I--MEDICAID PROVISIONS TO ADDRESS THE OPIOID CRISIS (Sec. 1001) The bill prohibits terminati... [HB6 2017 Detail][HB6 2017 Text][HB6 2017 Comments] | 2018-10-24 Became Public Law No: 115-271. |
| 2015-2016 114th Congress (Engrossed - Dead) | 21st Century Cures Act (Sec. 2) The NIH and Cures Innovation Fund is established and funds are appropriated: (1) for biomedical research, including high-risk, high-reward research and research conducted by early stage investigators; (2) to develop an... [HB6 2015 Detail][HB6 2015 Text][HB6 2015 Comments] | 2015-07-13 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| 2013-2014 113th Congress (Engrossed - Dead) | Domestic Prosperity and Global Freedom Act - (Sec. 2) Directs the Department of Energy (DOE), for proposals that must also obtain authorization from the Federal Energy Regulatory Commission or the United States Maritime Administration to site, constr... [HB6 2013 Detail][HB6 2013 Text][HB6 2013 Comments] | 2014-06-26 Received in the Senate. |
References Online
Legislative Citation
APA
US HB6 | 2015-2016 | 114th Congress. (2015, July 13). LegiScan. Retrieved June 17, 2026, from https://legiscan.com/US/bill/HB6/2015
MLA
"US HB6 | 2015-2016 | 114th Congress." LegiScan. LegiScan LLC, 13 Jul. 2015. Web. 17 Jun. 2026. <https://legiscan.com/US/bill/HB6/2015>.
Chicago
"US HB6 | 2015-2016 | 114th Congress." July 13, 2015 LegiScan. Accessed June 17, 2026. https://legiscan.com/US/bill/HB6/2015.
Turabian
LegiScan. US HB6 | 2015-2016 | 114th Congress. 13 July 2015. https://legiscan.com/US/bill/HB6/2015 (accessed June 17, 2026).
Subjects
Administrative law and regulatory procedures
Advisory bodies
Budget deficits and national debt
Child health
Computers and information technology
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Energy storage, supplies, demand
Europe
Executive agency funding and structure
Food and Drug Administration (FDA)
Fraud offenses and financial crimes
Government studies and investigations
Health
Health care quality
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Home and outpatient care
Hospital care
Immunology and vaccination
Infectious and parasitic diseases
International organizations and cooperation
Manufacturing
Medicaid
Medical education
Medical research
Medicare
National Institutes of Health (NIH)
Neurological disorders
Oil and gas
Prescription drugs
Product safety and quality
Public-private cooperation
Research administration and funding
Right of privacy
Strategic materials and reserves
Surgery and anesthesia
User charges and fees
Advisory bodies
Budget deficits and national debt
Child health
Computers and information technology
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Energy storage, supplies, demand
Europe
Executive agency funding and structure
Food and Drug Administration (FDA)
Fraud offenses and financial crimes
Government studies and investigations
Health
Health care quality
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Home and outpatient care
Hospital care
Immunology and vaccination
Infectious and parasitic diseases
International organizations and cooperation
Manufacturing
Medicaid
Medical education
Medical research
Medicare
National Institutes of Health (NIH)
Neurological disorders
Oil and gas
Prescription drugs
Product safety and quality
Public-private cooperation
Research administration and funding
Right of privacy
Strategic materials and reserves
Surgery and anesthesia
User charges and fees
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| HB2337 | Related | 2015-05-15 | To amend the Federal Food, Drug, and Cosmetic Act to authorize priority review for breakthrough devices. | Referred to the Subcommittee on Health. |
| HB2338 | Related | 2015-05-15 | To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes. | Referred to the Subcommittee on Health. |
| HCR46 | Related | 2015-05-15 | Expressing the sense of the Congress that the National Institutes of Health should encourage a global pediatric clinical trial network, and for other purposes. | Referred to the Subcommittee on Health. |
| HB292 | Related | 2015-01-16 | Advancing Research for Neurological Diseases Act of 2015 | Referred to the Subcommittee on Health. |
| HB2298 | Related | 2015-06-01 | Medicare Patient Safety and Drug Abuse Prevention Act | Referred to the Subcommittee on Health. |
| HB2299 | Related | 2015-06-01 | To amend title XVIII of the Social Security Act to provide for site-of-service price transparency under the Medicare program. | Referred to the Subcommittee on Health. |
| SB849 | Related | 2016-04-04 | Advancing Research for Neurological Diseases Act of 2016 | Placed on Senate Legislative Calendar under General Orders. Calendar No. 408. |
| HB2396 | Related | 2015-05-22 | SOFTWARE Act Sensible Oversight for Technology which Advances Regulatory Efficiency Act | Referred to the Subcommittee on Health. |
| HB2414 | Related | 2015-05-22 | To facilitate the responsible communication of scientific and medical developments. | Referred to the Subcommittee on Health. |
| HB2415 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of a streamlined data review program. | Referred to the Subcommittee on Health. |
| HB2419 | Related | 2015-05-22 | To amend the Public Health Services Act to reauthorize funding for the National Institutes of Health. | Referred to the Subcommittee on Health. |
| HB2420 | Related | 2015-05-22 | To reduce administrative burdens on researchers. | Referred to the Subcommittee on Health. |
| HB2421 | Related | 2015-05-22 | To amend the Public Health Service Act to increase accountability at the National Institutes of Health. | Referred to the Subcommittee on Health. |
| HB2422 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessment. | Referred to the Subcommittee on Health. |
| HB2423 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence. | Referred to the Subcommittee on Health. |
| HB2424 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to training and oversight in least burdensome appropriate means concept. | Referred to the Subcommittee on Health. |
| HB2425 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to the recognition of standards. | Referred to the Subcommittee on Health. |
| HB2426 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to easing regulatory burden with respect to certain class I and class II devices. | Referred to the Subcommittee on Health. |
| HB2427 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to advisory committee process. | Referred to the Subcommittee on Health. |
| HB2428 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications. | Referred to the Subcommittee on Health. |
| HB2433 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to enhancing combination products review. | Referred to the Subcommittee on Health. |
| HB2435 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with regard to the Reagan-Udall Foundation. | Referred to the Subcommittee on Health. |
| HB2436 | Related | 2015-05-22 | To amend the Public Health Service Act with respect to appropriate age groupings to be included in research studies involving human subjects. | Referred to the Subcommittee on Health. |
| HB2438 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to broader application of Bayesian statistics and adaptive trial designs. | Referred to the Subcommittee on Health. |
| HB2439 | Related | 2015-05-22 | To amend the Public Health Service Act with respect to the Silvio O. Conte Senior Biomedical Research Service. | Referred to the Subcommittee on Health. |
| HB2440 | Related | 2015-05-22 | To amend the Public Health Service Act to improve loan repayment programs of the National Institutes of Health. | Referred to the Subcommittee on Health. |
| HB2443 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics. | Referred to the Subcommittee on Health. |
| HB2445 | Related | 2015-05-22 | To express the sense of Congress with respect to enabling Food and Drug Administration scientific engagement. | Referred to the Subcommittee on Health. |
| HB2448 | Related | 2015-05-22 | To amend the Public Health Service Act to authorize a program of high-risk, high-reward research. | Referred to the Subcommittee on Health. |
| HB2452 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information. | Referred to the Subcommittee on Health. |
| HB2455 | Related | 2015-05-22 | To amend the Federal Food, Drug, and Cosmetic Act with respect to precision medicine. | Referred to the Subcommittee on Health. |
| HB2456 | Related | 2015-05-22 | To amend the Public Health Service Act to ensure the sharing of data generated from research with the public. | Referred to the Subcommittee on Health. |
| HB2547 | Related | 2015-05-22 | Surrogate Endpoint Improvement and Utilization Act of 2015 | Referred to the Subcommittee on Health. |
| HB2548 | Related | 2015-05-22 | Pediatric Research Improvement Act of 2015 | Referred to the Subcommittee on Health. |
| HB2549 | Related | 2015-05-22 | To amend the HITECH Act with respect to accessing, sharing, and using health data for research purposes. | Referred to the Subcommittee on Health. |
| SB1421 | Related | 2015-05-21 | Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| HB2629 | Related | 2015-06-05 | Antibiotic Development to Advance Patient Treatment Act | Referred to the Subcommittee on Health. |
| HB2340 | Related | 2015-06-26 | To amend the Controlled Substances Import and Export Act to remove regulatory barriers to the re-exportation of controlled substances among members of the European Economic Area. | Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. |
| HR350 | Related | 2015-07-09 | Providing for consideration of the bill (H.B. 6) to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes. | Motion to reconsider laid on the table Agreed to without objection. |
| HB789 | Related | 2015-02-06 | Tick-Borne Disease Research Accountability and Transparency Act of 2015 | Referred to the Subcommittee on Health. |
| SB1913 | Related | 2015-07-30 | Stopping Medication Abuse and Protecting Seniors Act of 2015 | Read twice and referred to the Committee on Finance. |
| SB2187 | Related | 2015-10-21 | FDA Regulatory Efficiency Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB2188 | Related | 2015-10-21 | Rare Disease Innovation Act | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| SB2978 | Related | 2016-05-25 | Protect Continuing Physician Education and Patient Care Act | Read twice and referred to the Committee on Finance. |
